Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 1, February 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets
pp. 19-26(8)
Authors: Crispi, S.; Cardillo, I.; Spugnini, E. P.; Citro, G.; Menegozzo, S.; Baldi, A.

Favourites:Add to Favourites

γ  T Cell Modulation in Anticancer Treatment
pp. 27-36(10)
Authors: Caccamo, N.; Dieli, F.; Meraviglia, S.; Guggino, G.; Salerno, A.

Favourites:Add to Favourites

Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in Clinical and Molecular Selection of Patients
pp. 37-45(9)
Authors: Loupakis, F.; Bocci, G.; Pasqualetti, G.; Fornaro, L.; Salvatore, L.; Cremolini, C.; Masi, G.; Danesi, R.; Tacca, M. D.; Falcone, A.

Favourites:Add to Favourites

Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
pp. 46-54(9)
Authors: Santini, D.; Virzi, V.; Fratto, M. E.; Bertoldo, F.; Sabbatini, R.; Berardi, R.; Calipari, N.; Ottaviani, D.; Ibrahim, T.

Favourites:Add to Favourites

Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
pp. 55-67(13)
Authors: Russo, A.; Bronte, G.; Fulfaro, F.; Cicero, G.; Adamo, V.; Gebbia, N.; Rizzo, S.

Favourites:Add to Favourites

Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
pp. 68-79(12)
Authors: Ruzzo, A.; Graziano, F.; Canestrari, E.; Magnani, M.

Favourites:Add to Favourites

CETUXIMAB: From Bench to Bedside
pp. 80-95(16)
Authors: Vincenzi, B.; Zoccoli, A.; Pantano, F.; Venditti, O.; Galluzzo, S.

Favourites:Add to Favourites

Bid Mediates Anti-Apoptotic COX-2 Induction Through the IKKβ/NFκB Pathway Due to 5-MCDE Exposure
pp. 96-106(11)
Authors: Luo, W.; Li, J.; Zhang, D.; Cai, T.; Song, L.; Yin, X.-M.; Desai, D.; Amin, S.; Chen, J.; Huang, C.

Favourites:Add to Favourites

Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
pp. 107-116(10)
Authors: Vergara, D.; Tinelli, A.; Martignago, R.; Malvasi, A.; Chiuri, V. E.; Leo, G.

Favourites:Add to Favourites

Stat3 Orchestrates Tumor Development and Progression: The Achilles' Heel of Head and Neck Cancers?
pp. 117-126(10)
Authors: Masuda, M.; Wakasaki, T.; Suzui, M.; Toh, S.; Joe, A. K.; Weinstein, I. B.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more